EpiPen Nasal Spray Suffers Setback as FDA Seeks Fresh Study EpiPen Nasal Spray Suffers Setback as FDA Seeks Fresh Study
The regulator has declined to approve a nasal spray that would have been the first needle-free emergency treatment for allergic reactions.Reuters Health Information
Source: Medscape Allergy Headlines - September 20, 2023 Category: Allergy & Immunology Tags: Pediatrics News Source Type: news

' Nopioids ' for Chronic Pain: Only When Nothing Else Works ' Nopioids ' for Chronic Pain: Only When Nothing Else Works
Dr Neha Pathak interviews Dr Daniel Clauw about how opioids fit into the treatment armamentarium when managing chronic pain.Medscape Internal Medicine
Source: Medscape Today Headlines - September 20, 2023 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

Shortage of treatment for highly contagious itchy skin condition caused by tiny mites poses 'significant threat' to public health, UK health leaders warn
A shortage of key medications that treat scabies a highly contagious skin condition is a major threat senior UK dermatologists warn as they urge the Government to act to boost supplies.
Source: the Mail online | Health - September 20, 2023 Category: Consumer Health News Source Type: news

FDA refuses to okay first nasal spray for allergic reactions, firm says
It would have been the first needle-free treatment for serious allergic reactions triggered by certain foods, insect stings and medications.
Source: Washington Post: To Your Health - September 20, 2023 Category: Consumer Health News Authors: Laurie McGinley Source Type: news

Namibia: Breast Cancer, the Second-Most Common Cancer in Namibia
[Namibian] Breast cancer has affected the lives of countless Namibian women and their families, but Namibians are determined to improve breast cancer awareness, early detection, and treatment.
Source: AllAfrica News: Health and Medicine - September 20, 2023 Category: African Health Tags: Health and Medicine Namibia Noncommunicable Diseases Southern Africa Source Type: news

Researchers discover biomarker for tracking depression recovery
New deep brain stimulation device coupled with powerful AI may improve therapy for treatment-resistant depression.
Source: National Institutes of Health (NIH) News Releases - September 20, 2023 Category: American Health Source Type: news

Uganda: MSF Ends Support to HIV Programme in Arua After More Than 20 Years
[MSF] For over 20 years, Médecins Sans Frontières (MSF) has supported the Ministry of Health with treatment for people living with HIV/AIDS in the West Nile region of Uganda and more specifically, in the Arua district.
Source: AllAfrica News: Health and Medicine - September 20, 2023 Category: African Health Tags: Aid and Assistance HIV-Aids and STDs East Africa External Relations Health and Medicine International Organizations and Africa NGOs and Civil Society Uganda Source Type: news

The Man Who Thinks He Can Live Forever
In a neat little neighborhood in Venice, Calif., there’s a block of squat, similar homes, filled with mortals spending their finite days on the planet eating pizza with friends, blowing out candles on birthday cakes, and binging late-night television. Halfway down the street, there’s a cavernous black modern box. This is where Bryan Johnson is working on what he calls “the most significant revolution in the history of Homo sapiens.”  [time-brightcove not-tgx=”true”] Johnson, 46, is a centimillionaire tech entrepreneur who has spent most of the last three years in pursuit of a si...
Source: TIME: Health - September 20, 2023 Category: Consumer Health News Authors: Charlotte Alter Tags: Uncategorized feature Source Type: news

Dynamic Risk Assessment for HCC in Patients With Chronic HCV Dynamic Risk Assessment for HCC in Patients With Chronic HCV
The authors developed a model for identifying hepatocellular carcinoma risk factors in individuals with chronic HCV, across antiviral treatment status and interactions with cirrhosis.Journal of Viral Hepatitis
Source: Medscape Today Headlines - September 20, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA declines to approve first needle-free option to EpiPen
Federal regulators have declined to approve the first needle-free epinephrine treatment for people who suffer from severe allergic reactions, requesting its developer, ARS Pharmaceuticals, to conduct further testing.
Source: Health News - UPI.com - September 20, 2023 Category: Consumer Health News Source Type: news

One of the world's top hormone experts is suspended for gaining illicit access to confidential medical records of more than 100 patients being held by a competitor
Dr Marion Gluck, 73, known globally for her pioneering treatment of hormonal imbalances, asked another doctor for the sensitive log-in information 'as a favour'.
Source: the Mail online | Health - September 20, 2023 Category: Consumer Health News Source Type: news

How Much Do Patients Need to Know About a Potentially Risky Treatment?
An unapproved product made from umbilical cord blood was used at a prominent New York hospital. After an F.D.A. warning came an internal complaint: Patients should have been told.
Source: NYT Health - September 20, 2023 Category: Consumer Health News Authors: Ellen Gabler, Steve Eder and Allie Pitchon Tags: Hospitals Blood Biotechnology and Bioengineering Ethics and Official Misconduct Burst Biologics New York-Presbyterian Hospital Food and Drug Administration Surgery and Surgeons Regulation and Deregulation of Industry Medicine and Health Source Type: news

Four in five people with hypertension aren ’t adequately treated
Just one in five people with hypertension have controlled it, the World Health Organization said. Eighty per cent of people with hypertension don’t receive adequate treatment, according to the World Health Organization (WHO)'s first report on the topic. Though the condition is common with one in…#hypertension #tomfrieden #resolvetosavelives #cdc
Source: Reuters: Health - September 20, 2023 Category: Consumer Health News Source Type: news

OJJAARA (momelotinib), FDA Approved for the Treatment of Myelofibrosis in Adults with Anemia, Available at Biologics by McKesson
CARY, N.C., Sept. 20, 2023 —Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by GSK as a specialty pharmacy provider for OJJAARATM (momelotinib).
Source: McKesson News - September 20, 2023 Category: Information Technology Source Type: news

Epidemiology of work-related traumatic brain injury (wrTBI) and COVID-19 pandemic lockdown consequences: experience in a reference center in Chile - Wimmer Del Solar J, Rojas-L íbano D, Bastías Barra P, Cisternas Vera C, Chávez Martel P, Rozas Vidal JP, Ibáñez Rodríguez P, Fontecilla Villalobos E.
INTRODUCTION: Work-related Traumatic Brain Injury (wrTBI) is a frequent cause of chronic morbidity, mortality, and high treatment costs. Its causes are highly environmentally determined and were affected by COVID-19 pandemic lockdowns. OBJECTIVE: W...
Source: SafetyLit - September 20, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20